• Je něco špatně v tomto záznamu ?

Pathological cut-offs of global and regional brain volume loss in multiple sclerosis

T. Uher, M. Vaneckova, J. Krasensky, L. Sobisek, M. Tyblova, J. Volna, Z. Seidl, N. Bergsland, MG. Dwyer, R. Zivadinov, N. De Stefano, MP. Sormani, EK. Havrdova, D. Horakova,

. 2019 ; 25 (4) : 541-553. [pub] 20171116

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, pozorovací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006842

BACKGROUND: Volumetric MRI surrogate markers of disease progression are lacking. OBJECTIVE: To establish cut-off values of brain volume loss able to discriminate between healthy controls and MS patients. METHODS: In total, 386 patients after first demyelinating event suggestive of MS (CIS), 964 relapsing-remitting MS (RRMS) patients, 63 secondary-progressive MS (SPMS) patients and 58 healthy controls were included in this longitudinal study. A total of 11,438 MRI scans performed on the same MRI scanner with the same protocol were analysed. Annualised percentage changes of whole brain, grey matter, thalamus and corpus callosum volumes were estimated. We investigated cut-offs able to discriminate between healthy controls and MS patients. RESULTS: At a predefined specificity of 90%, the annualised percentage change cut-off of corpus callosum volume (-0.57%) was able to distinguish between healthy controls and patients with the highest sensitivity (51% in CIS, 48% in RRMS and 42% in SPMS patients). Lower sensitivities (22%-49%) were found for cut-offs of whole brain, grey matter and thalamic volume loss. Among CIS and RRMS patients, cut-offs were associated with greater accumulation of disability. CONCLUSION: We identified cut-offs of annualised global and regional brain volume loss rates able to discriminate between healthy controls and MS patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006842
003      
CZ-PrNML
005      
20210510121922.0
007      
ta
008      
200511s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/1352458517742739 $2 doi
035    __
$a (PubMed)29143562
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Uher, Tomas $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
245    10
$a Pathological cut-offs of global and regional brain volume loss in multiple sclerosis / $c T. Uher, M. Vaneckova, J. Krasensky, L. Sobisek, M. Tyblova, J. Volna, Z. Seidl, N. Bergsland, MG. Dwyer, R. Zivadinov, N. De Stefano, MP. Sormani, EK. Havrdova, D. Horakova,
520    9_
$a BACKGROUND: Volumetric MRI surrogate markers of disease progression are lacking. OBJECTIVE: To establish cut-off values of brain volume loss able to discriminate between healthy controls and MS patients. METHODS: In total, 386 patients after first demyelinating event suggestive of MS (CIS), 964 relapsing-remitting MS (RRMS) patients, 63 secondary-progressive MS (SPMS) patients and 58 healthy controls were included in this longitudinal study. A total of 11,438 MRI scans performed on the same MRI scanner with the same protocol were analysed. Annualised percentage changes of whole brain, grey matter, thalamus and corpus callosum volumes were estimated. We investigated cut-offs able to discriminate between healthy controls and MS patients. RESULTS: At a predefined specificity of 90%, the annualised percentage change cut-off of corpus callosum volume (-0.57%) was able to distinguish between healthy controls and patients with the highest sensitivity (51% in CIS, 48% in RRMS and 42% in SPMS patients). Lower sensitivities (22%-49%) were found for cut-offs of whole brain, grey matter and thalamic volume loss. Among CIS and RRMS patients, cut-offs were associated with greater accumulation of disability. CONCLUSION: We identified cut-offs of annualised global and regional brain volume loss rates able to discriminate between healthy controls and MS patients.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a atrofie $x patologie $7 D001284
650    _2
$a mozek $x diagnostické zobrazování $x patologie $7 D001921
650    _2
$a corpus callosum $x diagnostické zobrazování $x patologie $7 D003337
650    12
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a šedá hmota $x diagnostické zobrazování $x patologie $7 D066128
650    _2
$a lidé $7 D006801
650    _2
$a longitudinální studie $7 D008137
650    _2
$a magnetická rezonanční tomografie $x normy $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a roztroušená skleróza $x diagnóza $x diagnostické zobrazování $x patologie $7 D009103
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a thalamus $x diagnostické zobrazování $x patologie $7 D013788
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vaneckova, Manuela $u Department of Radiodiagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Krasensky, Jan $u Department of Radiodiagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Sobisek, Lukas $u Department of Statistics and Probability, University of Economics-Prague, Prague, Czech Republic.
700    1_
$a Tyblova, Michaela $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Volna, Jana $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Seidl, Zdenek $u Department of Radiodiagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Bergsland, Niels $u Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA/IRCCS 'S. Maria Nascente', Don Carlo Gnocchi Foundation, Milan, Italy.
700    1_
$a Dwyer, Michael G $u Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA.
700    1_
$a Zivadinov, Robert $u Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA/Translational Imaging Center, Clinical and Translational Science Institute, University at Buffalo, The State University of New York, Buffalo, NY, USA.
700    1_
$a De Stefano, Nicola $u Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
700    1_
$a Sormani, Maria Pia, $u Department of Health Science, University of Genoa, Genoa, Italy. $d 1967- $7 xx0260374
700    1_
$a Havrdova, Eva Kubala $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Horakova, Dana $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
773    0_
$w MED00006389 $t Multiple sclerosis (Houndmills, Basingstoke, England) $x 1477-0970 $g Roč. 25, č. 4 (2019), s. 541-553
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29143562 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20210510121922 $b ABA008
999    __
$a ok $b bmc $g 1525700 $s 1096898
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 25 $c 4 $d 541-553 $e 20171116 $i 1477-0970 $m Multiple sclerosis $n Mult Scler $x MED00006389
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Možnosti archivace